🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Register and join us June 27 at 11am ET. FDA 8th Annual COA-CCT Workshop. #OCEOutcomes23 fda.zoomgov.com/webinar/regist…

*** New publication*** Usability of #ePRO platform with #cancer sufferers➡️huge potential for communicating with clinicians! Now need to test feasibility in clinic! #patientreportedoutcomes CPROR Mel Calvert Dr Sarah Hughes Lee Aiyegbusi @UoB_IAHR cell.com/heliyon/pdf/S2…

🎉Congratulations to Prof Alastair Denniston on receipt of his prestigious National Institute for Health and Care Research Incubator award! 🙌 Prof Denniston will lead an Incubator focused on how #AI & other digital technologies should be regulated for use in #Healthcare ➡️Press release: bit.ly/42zBPvD

Lovely day in Sheffield at #UKPROMS many thanks to the organisers @jillcarton1 @ScHARRSheffield

Please join if you can. Patient generated data to inform the tolerability of drug products… exploring single item overall side effect impact with some fantastic experts in the #PRO field

Are you passionate about promoting equality, diversity and inclusion (#EDI) in research and searching for a new opportunity? We're looking for you! Apply by 3 July to join our team as an EDI Project Officer and drive EDI initiatives within our BRC: beta.jobs.nhs.uk/candidate/joba…

Superb networking and exchanging thoughts and new ideas at our @UoB_IAHR Away Day with KK Cheng and Tracy Roberts #weareIAHR

Dive into how #PatientReportedOutcomes are a “powerful tool to amplify the patient voice” in clinical care with Dr. Claire Snyder from Johns Hopkins Kimmel Cancer Center Johns Hopkins Bloomberg School of Public Health and presented at #ASCO23. ASCO vjoncology.com/video/bd9uuv0h…

Our @TLCstudy latest paper on Patient & Public Involvement in Health Research has just been published! Huge thanks to our patient partners! CPROR @UoB_IAHR Nature Medicine Long Covid SOS @longcovidsos.bsky.social Long Covid Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 To read/download it, please click here ⬇️⬇️⬇️ rdcu.be/dhkO2

New Review: Olalekan Lee Aiyegbusi, Mel Calvert & colleagues (including patient partners) synthesize a checklist of key considerations for conducting patient and public involvement & engagement in research. #TLCStudy #PPIE #LongCovid@CPROR_UoB @UoB_IAHR nature.com/articles/s4159…

NEW PUBLICATION! Konrad Maruszczyk reports results from #qualitative itvs with stakeholders on #PROs providing evidence of longer term tolerability & effectiveness in target population #PatientReportedOutcomes Mel Calvert Lee Aiyegbusi Tom Keeley sciencedirect.com/science/articl…

***NEW PUBLICATION*** Development and testing of an #ePRO solution for patients with inflammatory diseases in an early phase trial CPROR @UoB_IAHR UK Research and Innovation Innovate UK #electronicPRO #patientreportedoutcomes

Our patient partners are so talented! A little overwhelmed when we received this poem from one of our patient partners... #PatientAndPublicInvolvement Long COVID Physio Long Covid SOS @longcovidsos.bsky.social Long Covid Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 covid 19 long recovery CPROR @UoB_IAHR ⤵️⤵️⤵️

1/ NEW early phase dose-finding reporting guidelines for trial protocols (SPIRIT-DEFINE) and trial reports (CONSORT-DEFINE) to enhance transparency and reproducibility. The BMJ SPIRIT-DEFINE: bmj.com/content/383/bm… CONSORT-DEFINE: bmj.com/content/383/bm…

6/ At the core of all our work is the aim to improve clinical trials for the benefit of patients. Thanks to our incredible patient partners Andrew Kightley Dr. Dawn Richards, PhD Richard Stephens & Lesley Roberts for co-designing a dose-finding trial lay summary toolkit with us! tinyurl.com/bdhx7trs

Well done Konrad Maruszczyk PhD candidate CPROR @UoB_IAHR Mel Calvert Dr Christel McMullan 🎾 🇨🇵 🇮🇪 🇪🇺

Delighted to share that our systematic review on the effects of disease modifying therapies in multiple sclerosis has been published👇 Mel Calvert Lee Aiyegbusi CPROR sciencedirect.com/science/articl…

NEW PUBLICATION!!!! Our team at CPROR along with other colleagues have produced a list of recommendations to address respondent burden associated with #PRO assessment. To read our paper, click on this link --> rdcu.be/dzXrp ⬇️⬇️⬇️ @UoB_IAHR Lee Aiyegbusi Mel Calvert

Patient-reported outcomes are invaluable tools, but may impose a burden on patients; Olalekan Lee Aiyegbusi and colleagues provide a set of 19 recommendations to reduce respondent burden. #PROs Lee Aiyegbusi Mel Calvert CPROR nature.com/articles/s4159…

📢 A new network will foster collaboration among regulators, industry & researchers to identify regulatory strategies that address the unique challenges of advanced therapies - to ensure patients have timely access to transformative treatments. birminghambrc.nihr.ac.uk/news-and-event…